Keyphrases
5-hydroxymethylcytosine (5hmC)
28%
Ablative Fractional Photothermolysis
14%
Bioinformatics
35%
Cancer Epigenetics
35%
Cancer Genome
35%
Cell Death
7%
Cell-free DNA (cfDNA)
35%
Checkpoint Blockade
7%
Colorectal Cancer
35%
Combination Therapy
42%
CRISPR-Cas9 Screen
35%
Deep Learning
35%
DUSP4
14%
Early-onset Colorectal Cancer (EOCRC)
35%
Epitope Spreading
35%
Fitness Genes
21%
Genetic Dependency
35%
Genome-wide CRISPR Screening
7%
Health Disparities
35%
High-throughput Drug Screen
7%
Hydroxymethylation
35%
Imiquimod
14%
Immune Checkpoint Blockade
35%
Immune Checkpoint Inhibitors
35%
Inhibitor Combination
14%
Large Language Models
35%
Learning Healthcare
35%
Machine Learning
35%
MEK Inhibitor (MEKi)
35%
Melanocyte Lineage
35%
Melanocytes
14%
Melanoma
100%
Melanoma Cells
35%
Mitogen-activated Protein Kinase
14%
Multi-analyte
7%
Neoantigen
35%
Nilotinib
35%
Pigmentation
7%
PPP2R2A
7%
Proportion of Tumour
7%
Radiation mutagenesis
7%
Self-antigens
14%
Shared Neoantigens
7%
Synergistic Interaction
35%
Trametinib
7%
Tumor
35%
Tumor DNA
7%
Tumor Subtype
14%
Tyrosine Kinase Inhibitor
7%
Ultraviolet B Radiation
7%
Medicine and Dentistry
Cas9
35%
Cell Death
7%
Cell Line
13%
Cell Population
7%
Cell Signaling Pathway
5%
Clustered Regularly Interspaced Short Palindromic Repeat
42%
Combination Drug
7%
Combination Therapy
42%
Cytotoxic T-Cell
7%
Diseases
7%
Engraftment
7%
Epitope
35%
extracellular signal regulated kinase
7%
Gene Inactivation
5%
Genetic Screen
5%
Health Care
17%
Imiquimod
14%
Immune Checkpoint Blockade
35%
Immune Checkpoint Inhibitor
35%
Malignant Neoplasm
35%
MAPK Signaling
11%
MEK Inhibitor
35%
Melanocyte
35%
Melanoma
100%
Melanoma Cell
19%
Melanoma Cell Line
11%
Metastatic Melanoma
5%
Neoplasm
47%
Nilotinib
35%
Pancreas Adenocarcinoma
7%
Pigmentation
7%
Radiation Mutagenesis
7%
Self-antigens
14%
Somatic Mutation
7%
Specific Tumor
7%
T Cell
7%
Trametinib
7%
Tyrosine-Kinase Inhibitor
7%
Vitiligo
7%
Xenograft
7%
Immunology and Microbiology
Cell Death
5%
Cell Line
8%
Cell Population
5%
Clustered Regularly Interspaced Short Palindromic Repeat
8%
Cytotoxic T-Cell
5%
Engraftment
5%
Epitope
35%
Imiquimod
11%
Immune Checkpoint Blockade
35%
Lineages
35%
Melanocyte
35%
Melanoma Cell
8%
Mouse Model
5%
Mutagenesis
5%
Neoantigen
35%
Pigmentation
5%
Somatic Mutation
5%
T Cell
5%
Trametinib
8%
Tyrosine
8%
Ultraviolet B Radiation
5%
Vitiligo
5%
Wild Type
71%
Xenograft
8%